Alnylam Pharmaceuticals
ALNY
#690
Rank
โ‚ฌ32.40 B
Marketcap
242,72ย โ‚ฌ
Share price
-2.05%
Change (1 day)
-9.20%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company